Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs SiTime Corporation (SITM) Price & Performance

Neurocrine Biosciences IncTrade
SiTime CorporationTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs SiTime Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while SiTime Corporation trades at $598 (market cap $16.63B). The key difference: Neurocrine Biosciences Inc and SiTime Corporation are close in size by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals.

NBIXSITM
Market Cap
$17.40B$16.63B
Sector
HealthTechnology
52-Week High
$180.55$901.60
52-Week Low
$123.10$190.16
Enterprise Value
$16.49B$15.84B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About SiTime Corporation

SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.

Read more on SITM